Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pulse Biosciences Inc (PLSE)
:PLSE
Holding PLSE?
Track your performance easily
PLSE Stock Chart & Stats
Day’s Range― - ―
52-Week Range$6.60 - $22.69
Previous CloseN/A
Volume31.18K
Average Volume (3M)156.16K
Market Cap
$1.09B
Enterprise Value$1.00B
Total Cash (Recent Filing)$16.39M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta2.03
Next Earnings
Mar 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.81
Shares Outstanding61,516,678
10 Day Avg. Volume122,252
30 Day Avg. Volume156,157
Standard Deviation0.32
R-Squared0.09
Alpha0.03
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-30.10
P/FCF Ratio0.00
Enterprise Value/Market Cap0.92
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-41.16
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Pulse Biosciences News
PremiumCompany Announcements
Pulse Biosciences Updates Investors on Cardiac Innovations
PremiumCompany Announcements
Pulse Biosciences Appoints Paul LaViolette as CEO
PremiumCompany Announcements
Pulse Biosciences CEO Resigns Amid Leadership Transition
PremiumCompany Announcements
Pulse Biosciences’ Co-Chairman Plans Major Stock Purchase
PremiumCompany Announcements
Pulse Biosciences Reports Q3 2024 Financials and DevelopmentsOwnership Overview
80.53% Insiders
2.52% Mutual Funds
0.56% Other Institutional Investors
12.76% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
PLSE FAQ
What was Pulse Biosciences Inc’s price range in the past 12 months?
Pulse Biosciences Inc lowest stock price was $6.59 and its highest was $22.69 in the past 12 months.
What is Pulse Biosciences Inc’s market cap?
Pulse Biosciences Inc’s market cap is $1.09B.
When is Pulse Biosciences Inc’s upcoming earnings report date?
Pulse Biosciences Inc’s upcoming earnings report date is Mar 27, 2025 which is in 68 days.
How were Pulse Biosciences Inc’s earnings last quarter?
Pulse Biosciences Inc released its earnings results on Oct 30, 2024. The company reported -$0.156 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.156.
Is Pulse Biosciences Inc overvalued?
According to Wall Street analysts Pulse Biosciences Inc’s price is currently Overvalued.
Does Pulse Biosciences Inc pay dividends?
Pulse Biosciences Inc does not currently pay dividends.
What is Pulse Biosciences Inc’s EPS estimate?
Pulse Biosciences Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pulse Biosciences Inc have?
Pulse Biosciences Inc has 61,516,678 shares outstanding.
What happened to Pulse Biosciences Inc’s price movement after its last earnings report?
Pulse Biosciences Inc reported an EPS of -$0.156 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.637%.
Which hedge fund is a major shareholder of Pulse Biosciences Inc?
Currently, no hedge funds are holding shares in PLSE
---
Pulse Biosciences Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
PLSE Sentiment 70%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 10.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $60.2M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.7%
Last 30 Days ▲ 8.3%
Last 30 Days ▲ 8.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
112.16%
12-Months-Change
Fundamentals
Return on Equity
-70.28%
Trailing 12-Months
Asset Growth
41.10%
Trailing 12-Months
Company Description
Pulse Biosciences Inc
Pulse Biosciences, Inc. is a clinical stage electroceutical, an electrical energy based therapeutic, company pursuing commercial applications of its proprietary Nano-Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments uses a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Hayward, CA.
---
PLSE Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
Pulse Biosciences showed strong clinical and regulatory progress, particularly with their innovative nano-PFA technology, while facing financial challenges due to increased losses and expenses. The company's financial position has strengthened significantly, providing a solid foundation for future developments.Read More>---
Technical Analysis
Senseonics Holdings
―
VolitionRX
―
Accelerate Diagnostics
―
Castle Biosciences
―
OncoCyte
―
Corbus Pharmaceuticals
―
---